Emvision Medical Devices Ltd (AU:EMV) — Market Cap & Net Worth
Market Cap & Net Worth: Emvision Medical Devices Ltd (EMV)
Emvision Medical Devices Ltd (AU:EMV) has a market capitalization of $104.56 Million (AU$147.77 Million) as of June 21, 2026. Listed on the AU stock exchange, this Australia-based company holds position #19084 globally and #616 in its home market, demonstrating a -0.63% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Emvision Medical Devices Ltd's stock price AU$1.59 by its total outstanding shares 92938604 (92.94 Million). Review Emvision Medical Devices Ltd (EMV) total liabilities to assess the company's total debt and financial obligations.
Emvision Medical Devices Ltd Market Cap History: 2018 to 2026
Emvision Medical Devices Ltd's market capitalization history from 2018 to 2026. Data shows growth from $23.02 Million to $104.56 Million (24.55% CAGR).
Emvision Medical Devices Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Emvision Medical Devices Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
23.17x
Emvision Medical Devices Ltd's market cap is 23.17 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $23.02 Million | $492.67K | -$845.04K | 46.72x | N/A |
| 2019 | $48.33 Million | $1.14 Million | -$2.96 Million | 42.57x | N/A |
| 2020 | $205.17 Million | $980.72K | -$5.08 Million | 209.20x | N/A |
| 2021 | $176.24 Million | $1.70 Million | -$8.40 Million | 103.74x | N/A |
| 2022 | $121.66 Million | $4.36 Million | -$6.11 Million | 27.90x | N/A |
| 2023 | $111.46 Million | $6.97 Million | -$3.87 Million | 15.98x | N/A |
| 2024 | $124.62 Million | $11.22 Million | -$2.73 Million | 11.11x | N/A |
| 2025 | $117.05 Million | $5.05 Million | -$9.81 Million | 23.17x | N/A |
Competitor Companies of EMV by Market Capitalization
Companies near Emvision Medical Devices Ltd in the global market cap rankings as of June 21, 2026.
Key companies related to Emvision Medical Devices Ltd by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #147 globally with a market cap of $153.73 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #207 globally with a market cap of $117.79 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #234 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #247 globally with a market cap of $101.86 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #147 | Abbott Laboratories | NYSE:ABT | $153.73 Billion | $88.41 |
| #207 | Stryker Corporation | NYSE:SYK | $117.79 Billion | $307.80 |
| #234 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #247 | Medtronic PLC | NYSE:MDT | $101.86 Billion | $79.34 |
Emvision Medical Devices Ltd Historical Marketcap From 2018 to 2026
Between 2018 and today, Emvision Medical Devices Ltd's market cap moved from $23.02 Million to $ 104.56 Million, with a yearly change of 24.55%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$104.56 Million | -10.67% |
| 2025 | AU$117.05 Million | -6.07% |
| 2024 | AU$124.62 Million | +11.80% |
| 2023 | AU$111.46 Million | -8.38% |
| 2022 | AU$121.66 Million | -30.97% |
| 2021 | AU$176.24 Million | -14.10% |
| 2020 | AU$205.17 Million | +324.49% |
| 2019 | AU$48.33 Million | +110.00% |
| 2018 | AU$23.02 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 21st, 2026 the market cap of Emvision Medical Devices Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $104.56 Million USD |
| MoneyControl | $104.56 Million USD |
| MarketWatch | $104.56 Million USD |
| marketcap.company | $104.56 Million USD |
| Reuters | $104.56 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Emvision Medical Devices Ltd
EMVision Medical Devices Ltd engages in the research, development, and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, and other medical imaging needs in Australia. It offers non-invasive brain scanners, including emu Brain Scanner, a bedside device; and First Responder Brain Scanner, a device embedded in standard road and air ambulances to deliver pre-hospita… Read more